NCT06793410 2025-06-05
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
Vastra Gotaland Region
Phase 2 Recruiting
Clinical Trials
16 trialsNCT06560879 2025-03-14
Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children with Leukemia
National Institute of Pediatrics, Mexico
Phase 2 Enrolling by invitation
NCT06480630 2024-06-28
Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases
Anhui Provincial Hospital
Phase 2 Not yet recruiting
NCT03493646 2024-05-28
Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486
Kirby Institute
Phase 2 Completed
NCT04989335 2023-11-28
Bisantrene Combination for Resistant AML
Sheba Medical Center
Phase 2 Unknown
NCT06105658 2023-10-30
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML
Anhui Provincial Hospital
Phase 2 Unknown
NCT05648019 2023-03-09
CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
KK Women's and Children's Hospital
Phase 2 Recruiting
NCT03022747 2017-01-16
Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol
Vastra Gotaland Region
Phase 2 Unknown
NCT01051154 2016-08-22
DHA-ALL
Coordinación de Investigación en Salud, Mexico
Phase 2 Completed
NCT00750659 2016-04-20
Nilotinib Pre and Post Allogeneic Stem Cell Transplantation
Sheba Medical Center
Phase 2 Completed
NCT01542944 2016-04-20
TevaGastrim for Stem Cell Mobilization Sibling Donors
Sheba Medical Center
Phase 2 Completed
NCT02507479 2016-04-20
Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies
Sheba Medical Center
Phase 2 Unknown
NCT00491634 2015-12-02
Treosulfan-based Conditioning for Transplantation in AML/MDS
Sheba Medical Center
Phase 2 Completed
NCT02275663 2015-01-06
Azacytidine Plus FLAG for Relapsed or Refractory AML
King Fahad Medical City
Phase 2 Unknown
NCT02113319 2014-04-14
DasaCBF
University Hospital, Angers
Phase 2 Completed
NCT00451711 2013-12-16
Intermittent Liposomal Amphotericin B Primary Prophylaxis
Bayside Health
Phase 2 Unknown